02050nas a2200241 4500000000100000008004100001653001700042653000900059653002200068653001800090653001600108653002400124653001800148653001800166653003000184653002000214100001100234700001500245700001200260700001500272245006300287520145800350 2017 d10askin disease10aSkin10aBurden of Disease10aGlobal health10aDermatology10adermatoepidemiology10aHealth equity10aTask shifting10aPoint-of-care diagnostics10aQuality of Life1 aSeth D1 aCheldize K1 aBrown D1 aFreeman EE00aGlobal burden of skin disease: Inequities and innovations.3 a

Purpose of Review

We review the current understanding of the burden of dermatological disease through the lens of the Global Burden of Disease project, evaluate the impact of skin disease on quality of life in a global context, explore socioeconomic implications, and finally summarize interventions towards improving quality of dermatologic care in resource-poor settings.

Recent Findings

The Global Burden of Disease project has shown that skin diseases continue to be the 4th leading cause of non-fatal disease burden worldwide. However, research efforts and funding do not match with the relative disability of skin diseases. International and national efforts, such as the WHO List of Essential Medicines, are critical towards reducing the socioeconomic burden of skin diseases and increasing access to care. Recent innovations such as teledermatology, point-of-care diagnostic tools, and task shifting help to provide dermatological care to underserved regions in a cost-effective manner.

Summary

Skin diseases cause significant non-fatal disability worldwide, especially in resource-poor regions. Greater impetus to study the burden of skin disease in low-resource settings and policy efforts towards delivering high-quality care are essential in improving the burden of skin diseases.